Journal article
Selective P450BM3 hydroxylation of the spiro[3.3]heptane core as a route to potential drug fragment molecules
- Abstract:
- Engineered P450BM3 enzyme variants, developed from an initial screening panel of 42 enzymes, convert N-benzyl spiro[3.3]heptane-2-carboxamide into three distally monohydroxylated regioisomers with essentially complete enantioselectivity. Two a-hydroxyamide derivatives are also produced. Elaboration of the metabolites by tethered C–H amination leadsto spiro[3.3]heptane motifs substituted with three different functional groups ready for further derivatization.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 1.5MB, Terms of use)
-
- Publisher copy:
- 10.1021/acs.orglett.5c01265
Authors
- Publisher:
- American Chemical Society
- Journal:
- Organic Letters More from this journal
- Volume:
- 27
- Issue:
- 36
- Pages:
- 9849–9853
- Publication date:
- 2025-08-27
- Acceptance date:
- 2025-08-22
- DOI:
- EISSN:
-
1523-7052
- ISSN:
-
1523-7060
- Language:
-
English
- Pubs id:
-
2283652
- Local pid:
-
pubs:2283652
- Deposit date:
-
2025-08-22
- ARK identifier:
Terms of use
- Copyright holder:
- Zhang et al
- Copyright date:
- 2025
- Rights statement:
- © 2025 The Authors. Published by American Chemical Society. This publication is licensed under CC-BY 4.0 .
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record